Unknown

Dataset Information

0

Usage of EMBRACE(TM) in Gujarat, India: Survey of Paediatricians.


ABSTRACT: Aim. EMBRACE(TM) is an innovative, low cost infant warmer for use in neonates. It contains phase change material, which stays at constant temperature for 6 hours. We surveyed paediatricians using EMBRACE(TM) regarding benefits, risks, and setup in which it was used in Gujarat. Methods. Questionnaire was administered telephonically to 52 out of 53 paediatricians. Results. EMBRACE(TM) was used for an average of 8.27 (range of 3-18, SD = 3.84) months by paediatricians. All used it for thermoregulation during transfers, for average (SD) duration of 42 (0.64)?m per transfer, 62.7% used it at mother's side for average (SD) 11.06 (7.89)?h per day, and 3.9% prescribed it at home. It was used in low birth weight neonates only by 56.9% while 43.1% used it for all neonates. While hyperthermia was not reported, 5.9% felt that EMBRACE(TM) did not prevent hypothermia. About 54.9% felt that they could not monitor the newborn during EMBRACE(TM) use. Of paediatricians who practiced kangaroo mother care (KMC), 7.7% have limited/stopped/decreased the practice of KMC and substituted it with EMBRACE(TM). Conclusions. EMBRACE(TM) was acceptable to most but concerns related to monitoring neonates and disinfection remained. Most paediatricians felt that it did not hamper KMC practice.

SUBMITTER: Nimbalkar S 

PROVIDER: S-EPMC4230002 | biostudies-other | 2014

REPOSITORIES: biostudies-other

altmetric image

Publications

Usage of EMBRACE(TM) in Gujarat, India: Survey of Paediatricians.

Nimbalkar Somashekhar S   Patel Harshil H   Dongara Ashish A   Patel Dipen V DV   Bansal Satvik S  

Advances in preventive medicine 20141030


Aim. EMBRACE(TM) is an innovative, low cost infant warmer for use in neonates. It contains phase change material, which stays at constant temperature for 6 hours. We surveyed paediatricians using EMBRACE(TM) regarding benefits, risks, and setup in which it was used in Gujarat. Methods. Questionnaire was administered telephonically to 52 out of 53 paediatricians. Results. EMBRACE(TM) was used for an average of 8.27 (range of 3-18, SD = 3.84) months by paediatricians. All used it for thermoregulat  ...[more]

Similar Datasets

| S-EPMC7552153 | biostudies-literature
| S-EPMC4047490 | biostudies-literature
| S-EPMC7213905 | biostudies-literature
| S-EPMC6173418 | biostudies-literature
| S-EPMC4934514 | biostudies-literature
| S-EPMC4017274 | biostudies-literature
| S-EPMC4247159 | biostudies-literature
| S-EPMC8118652 | biostudies-literature
| S-EPMC3515440 | biostudies-other
| S-EPMC4909767 | biostudies-literature